Breast Cancer Risk Assessment and Management Program
NCT07911592, Not applicable, Enrolling by invitation, Abramson Cancer Center at Penn Medicine
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Breast Cancer Risk Assessment and Management Program | ClinicalTrials.gov |
| NCT number | NCT07911592 | ClinicalTrials.gov |
| Status | Enrolling by invitation | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 1,000 participants, estimated | ClinicalTrials.gov |
| Lead sponsor | Abramson Cancer Center at Penn Medicine | ClinicalTrials.gov |
| Conditions | Genetic Predisposition to Cancer | ClinicalTrials.gov |
| Interventions | Patient nudge via text message, Patient nudge via phone call | ClinicalTrials.gov |
| First posted | 2026-11-03 | ClinicalTrials.gov |
| Last updated | 2026-11-03 | ClinicalTrials.gov |
Registered outcomes 5
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Uptake of EVA with initial SMS contact | 1 month | Uptake is the proportion of subjects who engage the EVA within the first month after contact | ClinicalTrials.gov |
| Primary | Uptake of EVA after patient nudge | 3 months | Uptake will be summarized as a proportion of individuals who adopt EVA after patient nudge compared to those with no additional nudge. The effect of additional patient support is a comparison of proportions and will be summarized as an odds ratio | ClinicalTrials.gov |
| Secondary | Uptake of digital counseling intervention | 4 months | Proportion of participants eligible for genetic testing who proceed with the digital counseling intervention | ClinicalTrials.gov |
| Secondary | Uptake of genetic testing | 3 months | Proportion of participants eligible for genetic testing who complete genetic testing | ClinicalTrials.gov |
| Secondary | Uptake of breast imaging | 12 months | Proportion of participants deemed at elevated risk for breast cancer who complete screening breast imaging | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)